Oscar M Rueda

Oscar M Rueda

University of Cambridge

H-index: 50

Europe-United Kingdom

About Oscar M Rueda

Oscar M Rueda, With an exceptional h-index of 50 and a recent h-index of 44 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of statistics, Cancer genomics, bioinformatics, computational biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clustering of HR+/HER2− breast cancer in an Asian cohort is driven by immune phenotypes

Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer

Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer

Evaluation and comparison of different breast cancer prognosis scores based on gene expression data

Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis

Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy

Breast tumor microenvironment structures are associated with genomic features and clinical outcome

Oscar M Rueda Information

University

Position

MRC Investigator Programme Leader Track MRC-BSU.

Citations(all)

21546

Citations(since 2020)

12811

Cited By

14006

hIndex(all)

50

hIndex(since 2020)

44

i10Index(all)

83

i10Index(since 2020)

74

Email

University Profile Page

University of Cambridge

Google Scholar

View Google Scholar Profile

Oscar M Rueda Skills & Research Interests

statistics

Cancer genomics

bioinformatics

computational biology

Top articles of Oscar M Rueda

Title

Journal

Author(s)

Publication Date

Clustering of HR+/HER2− breast cancer in an Asian cohort is driven by immune phenotypes

Breast Cancer Research

Jia-Wern Pan

Mohana Ragu

Wei-Qin Chan

Siti Norhidayu Hasan

Tania Islam

...

2024/4/22

Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer

Nature Metabolism

Peter Kreuzaler

Paolo Inglese

Avinash Ghanate

Ersa Gjelaj

Vincen Wu

...

2023/11

Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer

EMBO molecular medicine

Angela Santonja

Wendy N Cooper

Matthew D Eldridge

Paul AW Edwards

James A Morris

...

2023/6/7

Evaluation and comparison of different breast cancer prognosis scores based on gene expression data

Breast Cancer Research

Avirup Chowdhury

Paul D Pharoah

Oscar M Rueda

2023/2/8

Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment

Nature Cancer

Laura Kuett

Raúl Catena

Alaz Özcan

Alex Plüss

Peter Schraml

...

2022/1

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis

Scientific Reports

Debra Van Egeren

Khushi Kohli

Jeremy L Warner

Philippe L Bedard

Gregory Riely

...

2022/11/9

Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy

British journal of cancer

Tom van den Bosch

Oscar M Rueda

Carlos Caldas

Louis Vermeulen

Daniël M Miedema

2022/10/19

Breast tumor microenvironment structures are associated with genomic features and clinical outcome

Nature genetics

Esther Danenberg

Helen Bardwell

Vito RT Zanotelli

Elena Provenzano

Suet-Feung Chin

...

2022/5

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors

Cell reports

Nishanth Belugali Nataraj

Ashish Noronha

Joo Sang Lee

Soma Ghosh

Harsha Raj Mohan Raju

...

2022/2/22

Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies

Elife

Sophia A Wild

Ian G Cannell

Ashley Nicholls

Katarzyna Kania

Dario Bressan

...

2022/12/16

Multi-omic machine learning predictor of breast cancer therapy response

Nature

Stephen-John Sammut

Mireia Crispin-Ortuzar

Suet-Feung Chin

Elena Provenzano

Helen A Bardwell

...

2022/1/27

Single-cell genomic variation induced by mutational processes in cancer

Nature

Tyler Funnell

Ciara H O’Flanagan

Marc J Williams

Andrew McPherson

Steven McKinney

...

2022/12/1

Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune …

International journal of cancer

Jia‐Wern Pan

Muhammad Mamduh Ahmad Zabidi

Boon‐Keat Chong

Mei‐Yee Meng

Pei‐Sze Ng

...

2021/5/15

Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y León (Spain)

PLoS One

Pedro C Álvarez-Esteban

Eustasio Del Barrio

Oscar M Rueda

Cristina Rueda

2021/9/20

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses

NPJ breast cancer

Pei Sze Ng

Jia Wern Pan

Muhammad Mamduh Ahmad Zabidi

Pathmanathan Rajadurai

Cheng Har Yip

...

2021/4/23

DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation

Nature communications

Rajbir Nath Batra

Aviezer Lifshitz

Ana Tufegdzic Vidakovic

Suet-Feung Chin

Ankita Sati-Batra

...

2021/9/13

Hyperpolarized carbon-13 MRI for early response assessment of neoadjuvant chemotherapy in breast cancer patients

Cancer research

Ramona Woitek

Mary A McLean

Stephan Ursprung

Oscar M Rueda

Raquel Manzano Garcia

...

2021/12/1

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response

Nature communications

Dimitra Georgopoulou

Maurizio Callari

Oscar M Rueda

Abigail Shea

Alistair Martin

...

2021/3/31

Clonal fitness inferred from time-series modelling of single-cell cancer genomes

Nature

Sohrab Salehi

Farhia Kabeer

Nicholas Ceglia

Mirela Andronescu

Marc J Williams

...

2021/7/22

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

Breast Cancer Research

Silvana Mouron

Luis Manso

Eduardo Caleiras

Jose L Rodriguez-Peralto

Oscar M Rueda

...

2021/12

See List of Professors in Oscar M Rueda University(University of Cambridge)

Co-Authors

H-index: 160
Paul Pharoah

Paul Pharoah

University of Cambridge

H-index: 146
Carlos Caldas

Carlos Caldas

University of Cambridge

H-index: 66
Suet Feung Chin

Suet Feung Chin

University of Cambridge

H-index: 51
Nitzan Rosenfeld

Nitzan Rosenfeld

University of Cambridge

H-index: 51
Christina Curtis

Christina Curtis

Stanford University

H-index: 38
Florian Markowetz

Florian Markowetz

University of Cambridge

academic-engine